From July 1, 2022 to September 30, 2022, the company has repurchased 30,000 shares, representing 0.09% for KRW 461 million. With this, the company has completed the repurchase of 1,638,038 shares, representing 4.63% for KRW 27,613.64 million under the buyback announced on March 24, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6,410 KRW | +2.40% | -0.62% | -28.54% |
2023 | Access Bio, Inc. acquired an unknown minority stake in CuraPatient Inc. | CI |
2023 | Tranche Update on Access Bio, Inc.'s Equity Buyback Plan announced on March 24, 2022. | CI |
1st Jan change | Capi. | |
---|---|---|
-28.54% | 158M | |
+1.69% | 12.95B | |
-7.57% | 7.84B | |
+3.22% | 5.5B | |
+0.93% | 4.61B | |
+8.48% | 4.61B | |
+9.21% | 2.66B | |
-13.87% | 2.08B | |
-11.63% | 1.72B | |
+3.45% | 1.79B |
- Stock Market
- Equities
- A950130 Stock
- News Access Bio, Inc.
- Tranche Update on Access Bio, Inc.'s Equity Buyback Plan announced on March 24, 2022.